Related Experiment Videos
Percutaneous cholecystostomy in critically ill patients.
S K Teplick1, D L Harshfield, J C Brandon
1Department of Radiology, University of Arkansas for Medical Sciences, Little Rock 72205.
Summary
Percutaneous cholecystostomy offers a potential treatment for acute cholecystitis in critically ill patients. However, this study found a lower success rate and high mortality in this patient group.
Area of Science:
- Medical Procedures
- Gastroenterology
- Critical Care Medicine
Background:
- Acute cholecystitis is a common condition requiring intervention.
- Critically ill patients present unique challenges for surgical and interventional procedures.
- Percutaneous cholecystostomy is an alternative to surgery for acute cholecystitis.
Purpose of the Study:
- To reassess the value and success rate of percutaneous cholecystostomy.
- To evaluate the outcomes of percutaneous cholecystostomy in critically ill patients.
- To identify factors influencing the success of this procedure in a high-risk population.
Main Methods:
- Retrospective review of sixteen critically ill patients undergoing percutaneous cholecystostomy for suspected acute cholecystitis.
- Analysis of procedural success, patient outcomes, and subsequent interventions.
- Correlation of imaging findings (CT/ultrasound) with clinical outcomes.
Main Results:
- The procedure was technically successful in all sixteen patients.
- Eleven patients (69%) died due to underlying conditions, irrespective of the intervention.
- Four of eleven patients with definite acute cholecystitis were cured; three required surgery for gallbladder wall necrosis.
- Two of these surgical cases had pericholecystic fluid on imaging.
- Five patients with undetermined acute cholecystitis showed no improvement after the procedure.
Conclusions:
- Percutaneous cholecystostomy has a lower success rate in critically ill patients compared to previous reports.
- The presence of pericholecystic fluid may indicate a need for surgery.
- High mortality in this group is primarily due to severe underlying diseases.